UNSPSC 51131820: Coagulation factor vii

This classification denotes an antifibrinolytic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4156XVB4QD. European Medicines Agency schedules Coagulation factor viii in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Indices SUB32741 and SUB13811MIG. Coagulation factor vii bears US NLM identifiers UMLS ID C0015502 and NCI Concept Code C16570.

UNSPSC 51131820 Coagulation factor vii is a Commodity code, but the most recent state and local procurement activity tagged under it does not align with its nominal scope. The single recent opportunity on record—Sourcewell RFP #061626, posted May 12, 2026, with a June 16, 2026 response deadline—solicits law enforcement equipment through a cooperative purchasing vehicle, not pharmaceutical or blood-product therapies. The mismatch suggests either a tagging error in the source database or that coagulation factor VII procurement, if occurring under this code at all, is not currently generating visible RFP, RFQ, IFB, or ITB activity in state and local notice streams.

Sourcewell, a Minnesota local government unit and service cooperative operating under Washington state law (RCW 39.34), issued the law enforcement equipment RFP on behalf of participating entities including Franklin, Grant, Grays Harbor, Chelan, and Yakima counties in Washington, with the resulting contract available to thousands of governmental agencies, K-12 school districts, nonprofits, tribal governments, and public entities throughout the United States and Canada. Vendors must submit proposals exclusively through the Sourcewell Procurement Portal by June 16, 2026 at 3:30 p.m. Central Time. No set-aside designations, award values, or incumbent vendors are identified in the available documentation. The code shows no relevant recent activity beyond this single off-topic solicitation.